Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (Q167209): Difference between revisions

From geokb
(‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)
 
(‎Changed label, description and/or aliases in en, and other parts: removed aliases from OpenAlex keywords)
 
(2 intermediate revisions by the same user not shown)
aliases / en / 0aliases / en / 0
Chronic Lymphocytic Leukemia
aliases / en / 1aliases / en / 1
Genomic Aberrations
aliases / en / 2aliases / en / 2
BTK Inhibitors
aliases / en / 3aliases / en / 3
Rituximab
aliases / en / 4aliases / en / 4
Ibrutinib
aliases / en / 5aliases / en / 5
Prognostic Factors
aliases / en / 6aliases / en / 6
TP53 Mutation
aliases / en / 7aliases / en / 7
Waldenström Macroglobulinemia
aliases / en / 8aliases / en / 8
Immunoglobulin Mutation
aliases / en / 9aliases / en / 9
Therapeutic Targets
description / endescription / en
This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL)
Study of CLL's genetic mutations and treatment options.
Property / same as
 
Property / same as: https://openalex.org/T11157 / rank
Normal rank
 
Property / OpenAlex ID
 
Property / OpenAlex ID: T11157 / rank
 
Normal rank

Latest revision as of 21:11, 12 September 2024

Study of CLL's genetic mutations and treatment options.
Language Label Description Also known as
English
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
Study of CLL's genetic mutations and treatment options.

    Statements

    0 references
    0 references